When pushing through a difficult time, it is crucial for leaders to ensure the rest of their team is moving forward with them, Jon Sendach, president of Manhasset, N.Y.-based North Shore University Hospital, told Becker’s.
Category: Static
FDA approves schizophrenia treatment
The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults.
Unionization picks up after 'pharmageddon': 4 things to know
In the wake of 2023 walkouts by pharmacy workers dubbed “pharmageddon,” major chains such as Walgreens and CVS are facing increased pressure from their employees to provide better working conditions and wages.
Wisconsin blocks SSM Health nursing home sale
The Wisconsin Department of Health Services has denied the sale of three nonprofit SSM Health nursing facilities to a New Jersey-based for-profit company, the Wisconsin State Journal reported Sept. 27.
Health systems abandon rigid hierarchies
Health systems are relinquishing traditional leadership structures to reimagine a more effective healthcare delivery organization.
Why GLP-1s might treat a plethora of conditions
Hundreds of clinical trials are researching how drugs like Ozempic and Mounjaro affect a plethora of conditions, Nature reported Sept. 25.
Hospital CEO exits, by state, territory
A Challenger, Gray & Christmas report published Sept. 26 showed that 12 hospital CEOs left their roles in August, down from 16 reported in the same month last year. Those exits spanned the U.S., according to data provided to Becker’s by the executive c…
7 CEO moves at California hospitals in September
Becker’s has reported on multiple CEO moves at California-based hospitals and health systems in September, including resignations and new appointments.
Massachusetts seizes Steward hospital to prevent closure
Gov. Maura Healey has seized control of Dallas-based Steward Health Care’s St. Elizabeth’s Medical Center in Brighton, Mass., through eminent domain to ensure the hospital remains open and transfers operations to Boston Medical Center.
AbbVie drug shows promise in treating Parkinson's: 3 notes
AbbVie’s tavapadon has demonstrated positive results as a monotherapy for early Parkinson’s disease, according to a Sept. 26 news release from the drugmaker.
